Demcon life sciences & health

What Demcon life sciences & health does

Demcon life sciences & health is a Netherlands-based division of the privately-held Demcon Group that provides contract engineering and contract manufacturing services to the medical technology, biotechnology, and in-vitro diagnostics sectors. Founded in 1993 and headquartered in Enschede, the firm operates five locations across the Netherlands (Enschede HQ, Delft, Best, Maastricht) and Germany (Münster), employing 800+ engineers within the life sciences & health division as part of a group of 1,000+ professionals. It serves 100+ global clients, targeting both early-stage startups that lack in-house engineering depth and established OEMs needing specialized multidisciplinary capacity or contract manufacturing scale.

The company's technical platform integrates systems engineering, mechatronics, mechanics, electronics, optics, software & data science, QA/RA, and manufacturing under a structured six-phase development process running from concept through production. Demonstrated capabilities include precision fluidic pumps for ophthalmic surgery (DORC EVA), optical spectral transmission inflammation detection (Hemics HandScan), MRI-compatible robotic needle positioning (MIRIAM), nitinol steerable guidewires (Redwire), GMP-compliant bioreactors (SCINUS), ultra-fast PCR readers (miDiagnostics), and continuous monitoring wearables (viQtor for SmartQare). Proprietary mechatronic and process-control innovations (e.g., the DemcAir ventilation platform developed during COVID-19, closed-circuit therapeutic gas mixing) reflect deep cross-disciplinary know-how.

Demcon generates revenue primarily through project-based professional services engagements and contract manufacturing for medical devices, with all solutions delivered under ISO 13485, CE-MDR, CE-IVDR, FDA, and GMP frameworks. GTM is consultative and enterprise field-sales-driven via direct contact (no public pricing, bespoke quotations), with regional offices led by managing directors supporting local client relationships. The model is enhanced by participation in the broader Demcon Group ecosystem (including Demcon Macawi Respiratory Systems, the Demcon Innovation Center, and the Demcon Technology Center) and supplemented by minority venture investments in portfolio startups such as LiGalli and Kaminari Medical.

Name

Demcon life sciences & health

Legal name

DEMCON management & support B.V.

Website

https://lifescienceshealth.demcon.com

Company type

Private

Founded year

1993

Operating status

Operating

Headcount range

51–100 employees

Short description

Demcon life sciences & health is a Dutch contract engineering and manufacturing firm providing multidisciplinary product development services for medical technology, biotechnology, and in-vitro diagnostics companies, serving 100+ startups and OEMs globally with 800+ engineers across five locations.

Ownership category

akta.pro rank

Product category

Contract Medical Device Engineering & Manufacturing

NAICS

Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (54171)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Manufacturing Quality Assurance & GMP Compliance (batch release, deviation/CAPA, tech transfer QA) (HLAGAKAJ)

akta.pro secondary industries

Quality Engineering & Risk Management (ICH Q9/Q10, validation, change control) (HLAGAKAL), CMC, Process Development & Tech Transfer Staffing FSP (HLAGAOAK)

Keywords

• Contract medical engineering
• Medical device development
• In-vitro diagnostics
• Biotech contract manufacturing
• Mechatronics medical devices

Headquarters

HQ city

Enschede

HQ country

Netherlands

HQ region

Europe

Offices8 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Infrastructure, Operations, Marketing or Sales, Supply Chain

Revenue model

1. Contract engineering services: Full-service contract engineering covering the entire product development lifecycle from concept to production, including systems engineering, electronics, QA/RA, software & data science, optics, manufacturing, mechatronics, and mechanics. Revenue is generated through project-based professional service engagements with startups and OEM clients.
2. Contract manufacturing services: Manufacturing services including production of medical devices and systems, supporting clients through industrialization and production phases. Manufacturing capabilities include cleanroom facilities, miniaturized device assembly, and GMP-compliant production.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

Demcon life sciences & health provides contract engineering and contract manufacturing services for medical technology, biotechnology, and in-vitro diagnostics clients, spanning the entire product development lifecycle from concept to production. The firm serves both startups and OEMs, integrating multidisciplinary capabilities (mechatronics, electronics, optics, software, QA/RA, mechanics, and manufacturing) to deliver custom medical devices, diagnostic systems, treatment equipment, wearables, and biotech instrumentation under ISO 13485, CE-MDR, CE-IVDR, FDA, and GMP compliance frameworks.

Product overview

Demcon life sciences & health provides contract engineering and manufacturing services for medical technology, biotechnology, and in-vitro diagnostics companies. Their portfolio encompasses custom-developed medical devices and systems including diagnostic and monitoring equipment (HandScan, PCR test reader, spatial genomics analyzer), treatment systems (fluidic eye surgery pump, robotic endoscopes, needle placement robots, gas mixing platforms), critical care equipment (DemcAir ventilation), wearable health monitors (viQtor), biotech equipment (SCINUS bioreactor), and specialized instruments (Redwire guidewire, Switch suturing device, MedRing). They offer full-service product development from concept to production, serving both startups and OEM clients.

Differentiator

Problem solved

Functional benefit

Brands

• viQtor: 24/7 health monitoring wearable device developed in partnership with SmartQare for continuous vital signs monitoring, fall detection, and远程 patient care.
• Redwire
• SCINUS Bioreactor
• Demcon Macawi Respiratory Module
• MedRing

Products and services

• Contract Engineering Services

Quantifiable outcome

• Needle placement robot achieved less than 2mm margin of error at 25cm depth, enabling first-time-right liver cancer biopsies
• +7 more outcomes

Named customers22 records

Segments8 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

25 partnerships are on record, tiered core and minor.

• HaermonicscoreStrategic or Co-development Partner · 24 November 2022Long-term partnership since 2016 to develop the Haermonics Pure continuous flushing system preventing post-operative blood clots after open-heart surgery. Demcon handles all development, engineering, and production. Partnership formalized with CE certification of Haermonics Pure. Target of saving 10,000 lives annually by 2030.
• AAPM and IHE-RO Technical CommitteecoreStrategic or Co-development Partner · 23 August 2021Strategic partnership in radiation oncology combining AAPM's professional expertise, IHE-RO's technical committee standards, and Demcon's connectivity team track record. Focused on interoperability and connectivity by design in radiotherapy systems.
• NVisioncoreStrategic or Co-development PartnerPartnership for manufacturing and deployment of the POLARIS Preclinical system. NVision cited Demcon's extensive experience in designing and producing robust, user-friendly devices in both clinical and research settings as the reason for the partnership. Collaboration described as extremely successful.
• SmartQarecoreStrategic or Co-development PartnerKey development partner for viQtor 24/7 health monitoring wearable. Demcon developed the miniaturized device design integrating 300 components including sensors, wireless connectivity, and battery. Produced the first 50 CE-marked viQtor devices. Ongoing collaboration for living lab testing and market expansion.
• Scinus Cell ExpansioncoreStrategic or Co-development PartnerDevelopment partnership for next-generation SCINUS bioreactor system. Demcon designed and optimized a GMP-compliant tabletop device for cell cultivation and expansion using single-use bags. Collaboration combined Scinus's patented oxygenator and rocking system with Demcon's engineering and manufacturing capabilities.
• DORC (Dutch Ophthalmic Research Center)coreStrategic or Co-development PartnerPrimary development partner for the EVA eye surgery system. Demcon developed the novel fluidic pump technology from concept to production, providing superior stability and safety control for ophthalmic surgeries. DORC provided co-development and application expertise.
• University of TwentecoreStrategic or Co-development PartnerResearch partnership for MR-guided needle insertion robot (MIRIAM). University of Twente provided research facilities and continued follow-up research on needle-tissue interaction. Demcon delivered the prototype to UT for continued research.
• RadboudumccoreStrategic or Co-development PartnerClinical partnership for MR-guided needle insertion robot (MIRIAM). Provided MRI testing facilities and manikin testing for MRI compatibility validation. Collaboration on image distortion analysis.
• Erasmus Medical Center RotterdamcoreStrategic or Co-development PartnerClinical validation partnership for needle placement robot (28 patients studied); clinical validation for Haermonics Pure flushing system; Vaxtractor testing with Pfizer and Moderna vaccines; cervical cancer research project; Mellon Medical Switch suturing device validation.
• University Medical Center Groningen (UMCG)coreStrategic or Co-development PartnerClinical validation partnership for needle placement robot for liver cancer biopsies and ablations under CT guidance. Contributed to clinical study validating robot-supported needle placement method.
• miDiagnosticscoreStrategic or Co-development PartnerDeveloped ultra-fast PCR Covid-19 test reader within a year, achieving PCR results in 12 minutes. Close collaboration with miDiagnostics teams working on assay and disposable test card development. Supported CE-IVD certification.
• LaborieminorStrategic or Co-development PartnerEMC-proof redesign and corporate rebranding partnership for Flowstar uroflowmeter printer module. Addressed end-of-life component issues and modernized industrial design while maintaining functionality.
• Atlas (Wilfred Weijers)coreStrategic or Co-development PartnerVaxtractor vaccine extraction machine development and production partnership. Atlas devised the concept; Demcon handled further development and production. Collaboration with GGD Brabant-Zuidoost for user testing and Erasmus MC for clinical validation.
• IRE (Institut National des Radioéléments)coreStrategic or Co-development PartnerTechnical leadership partnership for SMART (Source of MedicAl RadioisoTopes) project. IRE leads the international collaboration of 25+ research institutes and companies working on sustainable radioisotope production using accelerator technology. Demcon designed the target and exposure unit capable of withstanding extreme heat from 3MW electron beam.
• ASMLcoreStrategic or Co-development PartnerTechnical guidance partnership for SMART project. ASML contributed electron accelerator technology originally developed for free-electron lasers and EUV lithography. Provided technical guidance for the SMART project alongside IRE.
• Veranome Biosystems (Applied Materials company)coreStrategic or Co-development PartnerDeveloped automated high-throughput spatial genomics analyzer — a compact tabletop system for Veranome Biosystems (an Applied Materials company). Turned initial lab setup into a commercial walk-away product including alpha and beta prototypes delivered within two years despite COVID travel restrictions.
• LiGallicoreStrategic or Co-development PartnerDevelopment and production partnership for MedRing vaginal drug delivery device. Demcon completed development and first production of the miniaturized ring integrating pump, reservoir, electronics, antenna, and battery. Demcon also joined as shareholder through investment. Partners working on new versions for other medicines and diagnostics.
• Kaminari MedicalcoreStrategic or Co-development PartnerDemcon life sciences & health already played a part in product development for Kaminari Medical's combined photoacoustic and ultrasound imaging technology for cardiovascular care. Demcon investment joined a €3.8M investment round (2024).
• Mellon MedicalcoreStrategic or Co-development PartnerDevelopment and production partnership for Switch suturing device. Demcon involved in further development and production of the innovative suturing instrument. Eurostars grant awarded to support development. Mellon Medical became part of Demcon Group in April 2024.
• Netherlands Organisation for Scientific Research (NWO) / Dutch Cancer SocietyminorStrategic or Co-development PartnerDemcon supports a 4-year research project 'For women, with women' to develop urine-based self-testing for cervical cancer using lab-on-a-chip technology. Demcon provides financial support and technical knowledge from its in-vitro diagnostics department.
• Demcon macawi respiratory systemscoreTechnology or IntegrationInternal group synergy: Demcon macawi's respiratory expertise combined with life sciences & health multidisciplinary engineering for respiratory/critical care products. Used as foundation for DemcAir ventilation system development.
• AssutminorStrategic or Co-development PartnerPartnership with Assut for development and production of suture sets for Mellon Medical's Switch suturing device.
• NXTGEN Hightech Biomed05 ConsortiumminorStrategic or Co-development PartnerDemcon organized a workshop as part of the Dutch Growth Fund Consortium NXTGEN Hightech, bringing together CDMOs, cell therapy developers, and technology providers to identify unmet needs in cell culture manufacturing.
• GGD Brabant-ZuidoostminorStrategic or Co-development PartnerCollaboration for user-friendliness analysis of Vaxtractor vaccine extraction machine. GGD staff provided feedback that helped improve the design and make it more user-friendly for healthcare workers.
• Erasmus MCcoreStrategic or Co-development PartnerVaxtractor validated in clinical practice using Pfizer and Moderna vaccines at Erasmus MC. Hospital pharmacist confirmed the machine can be used safely for large-scale Covid-19 vaccination. Also partner in cervical cancer self-testing research.

Scale indicators12 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Hamilton Bonaduz AG: Swiss-headquartered manufacturer of precision liquid handling, bioreactors, and process analytics equipment, with a strong Life Science and medical device presence. Comparable in developing high-precision biotech and medical instrumentation, particularly around bioreactors and laboratory automation.
• Phillips-Medisize: A leading global medical device CDMO offering design, development, and manufacturing services for drug delivery, diagnostic, and medtech products. Comparable to Demcon as a full-service outsourced development and manufacturing partner for medical devices across multiple end-markets.
• Tecan: Swiss manufacturer of laboratory automation and IVD instruments, including OEM solutions for diagnostic and life science companies. Comparable to Demcon in serving IVD developers with instrument design and manufacturing, particularly for high-throughput and point-of-care platforms.

Broad incumbents

• West Pharmaceutical Services: Global manufacturer of packaging, containment, and delivery solutions for injectable drugs and healthcare products, with strong contract manufacturing capabilities. Comparable in serving pharma and medtech OEMs with high-quality regulated manufacturing, though at larger scale and with deeper drug-delivery specialization.
• Drägerwerk: German-headquartered global medical and safety technology company specializing in critical care, ventilation, and patient monitoring. Comparable to Demcon's DemcAir ventilation and respiratory systems development, but operates as a fully integrated product company rather than a service provider.
• Sanmina: Global EMS provider with dedicated Medical, Diagnostics, and Life Sciences capabilities, offering design, manufacturing, and aftermarket services. Comparable to Demcon for medical device OEMs seeking outsourced manufacturing but with broader global footprint.
• Flex (Flextronics): Global contract manufacturer with a sizable medical device and diagnostics practice, providing design, manufacturing, and supply chain services. Comparable in serving medical OEMs but at significantly larger scale and broader geographic reach.
• Gerresheimer: European-headquartered global manufacturer of primary packaging, drug delivery devices, and medical technology products, with strong GMP manufacturing capabilities. Comparable in regulated medical device manufacturing serving pharma and medtech clients across Europe.
• Jabil Healthcare: One of the largest global contract manufacturers with a dedicated Healthcare division producing medical devices, diagnostics, and pharmaceutical delivery systems. A broader incumbent offering scale and geographic reach that exceeds Demcon's Netherlands/Germany footprint.

Emerging players

• Stratec SE: German-based partner for OEM development of fully automated analyzer systems for clinical diagnostics and biotechnology. Comparable in providing OEM instrument design and manufacturing for IVD and life science companies, with overlapping end-markets in diagnostics and biotech instrumentation.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/Demcon
• LinkedInlinkedin.com/company/demcon-life-sciences-and-health
• Xtwitter.com/demcon

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Subsidiaries4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Demcon life sciences & health